The p53 heterozygous rats also displayed a delay in tumour onset and a wider spectrum of tumour types, including breast cancer which suggested that these mutant rats might prove to be a useful model for the p53-associated Li-Fraumeni syndrome in humans. This evidence concerns the gene TP53 and neoplasm.